Abstract
Mosaic loss of Y (mLOY) is the most common somatic chromosomal alteration detected in human blood. The presence of mLOY is associated with altered blood cell counts and increased risk of Alzheimer's disease, solid tumors, and other age-related diseases. We sought to gain a better understanding of genetic drivers and associated phenotypes of mLOY through analyses of whole genome sequencing of a large set of genetically diverse males from the Trans-Omics for Precision Medicine (TOPMed) program. This approach enabled us to identify differences in mLOY frequencies across populations defined by genetic similarity, revealing a higher frequency of mLOY in the European American (EA) ancestry group compared to those of Hispanic American (HA), African American (AA), and East Asian (EAS) ancestry. Further, we identified two genes (CFHR1 and LRP6) that harbor multiple rare, putatively deleterious variants associated with mLOY susceptibility, show that subsets of human hematopoietic stem cells are enriched for activity of mLOY susceptibility variants, and that certain alleles on chromosome Y are more likely to be lost than others.
Introduction
As men age, their hematopoietic cells frequently undergo a spontaneous somatic mutation: the loss of the Y chromosome. This phenomenon, known as mosaic loss of Y (mLOY), is far more than a biological curiosity. It has been clinically linked to an increased risk of Alzheimer’s disease, cardiovascular complications, and various solid tumors. Despite its prevalence, our understanding of the genetic architecture and population-specific dynamics of mLOY has been constrained by technical and demographic limitations.
Previous research largely relied on SNP genotyping arrays, which lack the sensitivity to detect mLOY when it occurs in a small fraction of cells (low cell fraction). Furthermore, most studies have focused on populations of European or Japanese descent, leaving a gap in our understanding of how mLOY manifests across diverse genetic backgrounds. This study addresses these gaps by utilizing high-depth whole-genome sequencing (WGS) from a massive, ancestrally diverse cohort to map the genetic and phenotypic rules governing Y chromosome loss.
Methodology
The researchers leveraged data from the Trans-Omics for Precision Medicine (TOPMed) program, analyzing a cohort of 25,517 males across 13 different studies. The cohort was ancestrally diverse, including 14,059 European Americans, 7,653 African Americans, 2,838 Hispanic Americans, and 501 East Asians.
To detect mLOY with high precision, the team employed the MOsaic CHromosomal Alterations (MoChA) algorithm. Unlike traditional methods, MoChA utilizes haplotype information and allele-specific read depths in the pseudo-autosomal region 1 (PAR1) of the X and Y chromosomes. This WGS-based approach proved to be five times more sensitive than array-based methods, particularly for detecting events where the mutation was present in less than 10% of the cell population.
To identify genetic drivers, the study used aggregate tests (SKAT-O) to find genes with a high burden of rare, deleterious mutations. Additionally, the SCAVENGE tool was used to map genetic risk loci onto single-cell ATAC-seq data, allowing researchers to pinpoint the specific stages of blood cell development where these variants are most active.
Key Findings
Ancestry and Protective Alleles
The study revealed significant differences in mLOY prevalence across ancestry groups. European Americans (EA) exhibited the highest frequency of mLOY. In contrast, the odds of having mLOY were significantly lower in other groups: African Americans (OR=0.69), East Asians (OR=0.54), and Hispanic Americans (OR=0.80). This disparity is partly explained by the presence of protective alleles near genes such as TCL1A and BCL2L1, which appear more frequently in non-European populations and may guard against the clonal expansion of cells that have lost the Y chromosome.
Novel Genetic Drivers
Beyond common variants, the researchers identified rare, putatively deleterious variants in CFHR1 and LRP6 as significant risk factors for mLOY. These genes are highly expressed in hematopoietic stem cells (HSCs), suggesting that the predisposition for mLOY is rooted in the earliest stages of blood cell production. Furthermore, the loss of the Y chromosome is not always a random "blank slate" event; the study found that certain alleles in the CD99 gene are preferentially retained, suggesting a selective advantage for cells with specific genetic profiles post-loss.
Clonal Competition and Phenotypes
A fascinating "evolutionary trade-off" was discovered between mLOY and Clonal Hematopoiesis of Indeterminate Potential (CHIP). While both conditions increase with age, they appear to compete for the same cellular niche. Men with mLOY were found to be less likely to carry certain CHIP mutations, such as those in DNMT3A, suggesting that different mutant clones may outcompete one another within the bone marrow.
Clinically, mLOY was associated with distinct blood phenotypes, including higher white blood cell, neutrophil, and monocyte counts, but lower red blood cell counts. Additionally, telomere length emerged as a major predictor: every 1 kilobase decrease in telomere length was associated with a 27% increase in the odds of mLOY.
Conclusion and Future Directions
This research provides the most comprehensive map to date of the genetic factors influencing mLOY. By moving beyond SNP arrays to WGS and including diverse populations, the study identifies new rare-variant drivers and clarifies how ancestry influences somatic mutation rates.
However, the cross-sectional nature of the study means that the causal relationship between mLOY and altered blood counts remains to be fully established. Future longitudinal studies are required to track the competition between mLOY and CHIP clones over time. Understanding the molecular mechanisms by which genes like CFHR1 and LRP6 influence chromosome stability could eventually lead to interventions for the age-related diseases associated with Y chromosome loss.
Summary updated